Michael F. Bigham
2019
In 2019, Michael F. Bigham earned a total compensation of $2.2M as Executive Chairman of the Board at Paratek Pharmaceuticals, a 15% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $343,750 |
|---|---|
| Salary | $515,000 |
| Stock Awards | $1,352,100 |
| Other | $22,928 |
| Total | $2,233,778 |
Bigham received $1.4M in stock awards, accounting for 61% of the total pay in 2019.
Bigham also received $343.8K in non-equity incentive plan, $515K in salary and $22.9K in other compensation.
Rankings
In 2019, Michael F. Bigham's compensation ranked 5,362nd out of 13,971 executives tracked by ExecPay. In other words, Bigham earned more than 61.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,362 out of 13,971 | 62nd |
Division Manufacturing | 2,002 out of 5,701 | 65th |
Major group Chemicals And Allied Products | 709 out of 2,200 | 68th |
Industry group Drugs | 595 out of 1,886 | 69th |
Industry Pharmaceutical Preparations | 442 out of 1,398 | 68th |
Source: SEC filing on April 23, 2021.
Bigham's colleagues
We found two more compensation records of executives who worked with Michael F. Bigham at Paratek Pharmaceuticals in 2019.